April 2022
Attacking Acute Graft-Versus-Host Disease From Multiple Angles
April 28, 2022
Article
Acute graft-versus-host disease (aGVHD) is the most frequently encountered, life- threatening complication following an allogeneic hematopoietic stem cell transplant (aHSCT).
Upending Endometrial Cancer
April 27, 2022
Article
Two-thirds of women diagnosed with endometrial cancer have localized disease and a 5-year relative survival of 95%.
A String of Clinical Pearls for Immunotherapy in Non−Small Cell Lung Cancer
April 26, 2022
Article
An expert panel engaged the audience in a live virtual symposium and case discussion on immune checkpoint inhibitors (ICIs) in the first-line treatment of non−small cell lung cancer (NSCLC) at the 2021 ASHP Midyear Clinical Meeting.
Treatment for Myelodysplastic Syndromes: Who, When, and What
April 25, 2022
Article
Attendees of this live virtual program learned the latest and greatest in a presentation from 2 expert oncology pharmacists.
Supporting Oral Oncolytics in Follicular and Marginal Zone Lymphomas
April 22, 2022
Article
In a live virtual symposium at the 2021 ASHP Midyear Clinical Meeting, 2 experts teamed up to highlight the place in therapy and management of oral oncolytics in follicular and marginal zone lymphoma.
Using Mobocertinib to Treat Advanced NSCLC With EGFR Exon 20 Insertion Mutations
April 21, 2022
Article
The agent is the first oral therapy for this indication.
An Overview of the Expanding Treatment Landscape of Chronic Myeloid Leukemia
April 20, 2022
Article
Asciminib offers a new option for patients harboring the T315I mutation.
Niraparib as First-Line Maintenance Treatment of Ovarian, Fallopian Tube, Primary Peritoneal Cancer
April 19, 2022
Article
The oral PARP inhibitor is associated with increased PFS, regardless of BRCA mutational status.
Assessing the Landscape of HER2+ Breast Cancer Treatment
April 18, 2022
Article
New therapies and combination regimens may allow a more tailored approach.
Low Cancer Screening Rates Persist 2 Years Into Pandemic
April 14, 2022
Article
Numbers have remained below prepandemic levels.
Oncology Biosimilars Enter an Era of Expansion
April 13, 2022
Article
Biosimilars could save consumers more than $100 billion in the coming years.
Treatment Options for Squamous Cell Carcinoma
April 12, 2022
Article
Features
Cutaneous squamous cell carcinoma should be diagnosed early and treated promptly to avoid complications.
Pharmacists Can Improve Adherence to Oral Oncolytics
April 11, 2022
Article
A variety of strategies can help increase patient adherence to oral chemotherapy.
Oncology Formularies Have Arrived
April 04, 2022
Article
Oncology and specialty treatments advance alongside care.
Advancing Toward More Equitable Access to Oncology Care, Treatments
April 01, 2022
Article
We see today far more clearly the impact of health care inequality, which can directly affect patient access to care, specifically oncologic care.